Sudden unexpected death related to enterovirus myocarditis: histopathology, immunohistochemistry and molecular

Imed Gaaloul1, Samira Riabi, Rafik Harrath

  • 1Laboratory of Transmissible Diseases LR99-ES27, Faculty of Pharmacy, Avenue Avicenne, 5000, Monastir, Tunisia. chbeli_imed@yahoo.fr

BMC Infectious Diseases
|September 13, 2012
PubMed

Insights

Viral myocarditis, often caused by coxsackie B enterovirus, is a significant factor in sudden unexpected deaths. This study found a higher prevalence of viral myocarditis in victims compared to controls.

Area of Science:

  • Cardiology
  • Virology
  • Pathology

Background:

  • Viral myocarditis is a leading cause of sudden unexpected death in young individuals.
  • Coxsackievirus B3 (CVB3) has been historically linked to myocarditis.
  • Current diagnostic methods for myocarditis lack sensitivity, necessitating advanced approaches.

Purpose of the Study:

  • To investigate the prevalence of viral myocarditis in sudden unexpected death cases.
  • To identify the role of enteroviruses, specifically coxsackie B enterovirus, in myocarditis pathogenesis.
  • To compare findings in sudden unexpected death victims with control subjects.

Main Methods:

  • Post-mortem analysis of sudden unexpected death victims and controls.
  • Immunohistochemical detection of enteroviral capsid protein VP1.
  • Molecular pathology for enteroviral genome detection using RT-PCR.
  • Analysis of myocardial inflammatory reactions, including T and B lymphocytes.

Main Results:

  • Enterovirus was detected in 12.5% of sudden unexpected death cases, with none in controls.
  • Enteroviral capsid protein VP1 was identified in enterovirus-positive cases.
  • Sudden unexpected death victims showed a significant presence of T and B lymphocytes compared to controls.

Conclusions:

  • Viral myocarditis is more prevalent in sudden unexpected death cases than in controls.
  • Coxsackie B enterovirus likely plays a significant role in the pathogenesis of myocarditis.
  • Advanced diagnostic techniques enhance the understanding of myocarditis etiology.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...